Skip to main content

Fordyce Marshall's Form 4 filing

Vera Therapeutics, Inc. (VERA) · filed Aug 30, 2024

Accession no.
0001415889-24-022620
Filed
Aug 30, 2024
Trade date
Aug 28, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.12M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fordyce MarshallCIK 0001859453Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 28, 2024Class A Common StockMOption exerciseAcquired+14,925$2.90+$43,282.5337,592Direct
Aug 28, 2024Class A Common StockSSaleDisposed−14,925$36.80−$549,240322,667Direct
Aug 28, 2024Class A Common StockMOption exerciseAcquired+700$2.90+$2,030323,367Direct
Aug 28, 2024Class A Common StockSSaleDisposed−700$37.54−$26,278322,667Direct
Aug 28, 2024Class A Common StockSSaleDisposed−13,995$36.82−$515,295.9308,672Direct
Aug 28, 2024Class A Common StockSSaleDisposed−700$37.53−$26,271307,972Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 28, 2024Class A Common StockMOption exerciseDisposed−15,625$0.00$0842,962Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)